137 related articles for article (PubMed ID: 37815448)
21. Role of the Prostate Imaging Quality PI-QUAL Score for Prostate Magnetic Resonance Image Quality in Pathological Upstaging After Radical Prostatectomy: A Multicentre European Study.
Windisch O; Benamran D; Dariane C; Favre MM; Djouhri M; Chevalier M; Guillaume B; Oderda M; Gatti M; Faletti R; Colinet V; Lefebvre Y; Bodard S; Diamand R; Fiard G
Eur Urol Open Sci; 2023 Jan; 47():94-101. PubMed ID: 36601048
[TBL] [Abstract][Full Text] [Related]
22. Taking PI-QUAL beyond the prostate: Towards a standardized radiological image quality score (RI-QUAL).
Becker AS; Giganti F; Purysko AS; Fainberg J; Vargas HA; Woo S
Eur J Radiol; 2023 Aug; 165():110955. PubMed ID: 37421773
[TBL] [Abstract][Full Text] [Related]
23. Multiparametric prostate MRI quality assessment using a semi-automated PI-QUAL software program.
Giganti F; Lindner S; Piper JW; Kasivisvanathan V; Emberton M; Moore CM; Allen C
Eur Radiol Exp; 2021 Nov; 5(1):48. PubMed ID: 34738219
[TBL] [Abstract][Full Text] [Related]
24. Effect of a dedicated PI-QUAL curriculum on the assessment of prostate MRI quality.
Wang R; Pinto D; Liu T; Hamade M; Jubane M; Arif A; Boateng J; Maloney S; Amin A; Sandhu J; Nini S; Manov J; Tordjman L; Villavicencio J; Chamoun M; Leslom S; Aristizabal J; Felix M; Gomez-Rodriguez C; Alessandrino F
Eur J Radiol; 2023 Jul; 164():110865. PubMed ID: 37167684
[TBL] [Abstract][Full Text] [Related]
25. Comparing biparametric to multiparametric MRI in the diagnosis of clinically significant prostate cancer in biopsy-naive men (PRIME): a prospective, international, multicentre, non-inferiority within-patient, diagnostic yield trial protocol.
Asif A; Nathan A; Ng A; Khetrapal P; Chan VW; Giganti F; Allen C; Freeman A; Punwani S; Lorgelly P; Clarke CS; Brew-Graves C; Muirhead N; Emberton M; Agarwal R; Takwoingi Y; Deeks JJ; Moore CM; Kasivisvanathan V;
BMJ Open; 2023 Apr; 13(4):e070280. PubMed ID: 37019486
[TBL] [Abstract][Full Text] [Related]
26. Diagnostic accuracy of biparametric vs multiparametric MRI in clinically significant prostate cancer: Comparison between readers with different experience.
Di Campli E; Delli Pizzi A; Seccia B; Cianci R; d'Annibale M; Colasante A; Cinalli S; Castellan P; Navarra R; Iantorno R; Gabrielli D; Buffone A; Caulo M; Basilico R
Eur J Radiol; 2018 Apr; 101():17-23. PubMed ID: 29571792
[TBL] [Abstract][Full Text] [Related]
27. Bridging the experience gap in prostate multiparametric magnetic resonance imaging using artificial intelligence: A prospective multi-reader comparison study on inter-reader agreement in PI-RADS v2.1, image quality and reporting time between novice and expert readers.
Forookhi A; Laschena L; Pecoraro M; Borrelli A; Massaro M; Dehghanpour A; Cipollari S; Catalano C; Panebianco V
Eur J Radiol; 2023 Apr; 161():110749. PubMed ID: 36812699
[TBL] [Abstract][Full Text] [Related]
28. Synthetic magnetic resonance imaging for primary prostate cancer evaluation: Diagnostic potential of a non-contrast-enhanced bi-parametric approach enhanced with relaxometry measurements.
Arita Y; Akita H; Fujiwara H; Hashimoto M; Shigeta K; Kwee TC; Yoshida S; Kosaka T; Okuda S; Oya M; Jinzaki M
Eur J Radiol Open; 2022; 9():100403. PubMed ID: 35242886
[TBL] [Abstract][Full Text] [Related]
29. Multi-reader evaluation of different image quality scoring systems in prostate MRI.
Hötker AM; Njoh S; Hofer LJ; Held U; Rupp NJ; Ghafoor S; Stocker D; Eberli D; Donati OF
Eur J Radiol; 2023 Apr; 161():110733. PubMed ID: 36780738
[TBL] [Abstract][Full Text] [Related]
30. Utility of Quantitative T2-Mapping Compared to Conventional and Advanced Diffusion Weighted Imaging Techniques for Multiparametric Prostate MRI in Men with Hip Prosthesis.
Sathiadoss P; Schieda N; Haroon M; Osman H; Alrasheed S; Flood TA; Melkus G
J Magn Reson Imaging; 2022 Jan; 55(1):265-274. PubMed ID: 34223675
[TBL] [Abstract][Full Text] [Related]
31. Effect of Temporal Resolution on Diagnostic Performance of Dynamic Contrast-Enhanced Magnetic Resonance Imaging of the Prostate.
Othman AE; Falkner F; Weiss J; Kruck S; Grimm R; Martirosian P; Nikolaou K; Notohamiprodjo M
Invest Radiol; 2016 May; 51(5):290-6. PubMed ID: 26619282
[TBL] [Abstract][Full Text] [Related]
32. Quality of Prostate MRI: Is the PI-RADS Standard Sufficient?
Sackett J; Shih JH; Reese SE; Brender JR; Harmon SA; Barrett T; Coskun M; Madariaga M; Marko J; Law YM; Turkbey EB; Mehralivand S; Sanford T; Lay N; Pinto PA; Wood BJ; Choyke PL; Turkbey B
Acad Radiol; 2021 Feb; 28(2):199-207. PubMed ID: 32143993
[TBL] [Abstract][Full Text] [Related]
33. Deep Learning Super-Resolution Reconstruction for Fast and Motion-Robust T2-weighted Prostate MRI.
Bischoff LM; Peeters JM; Weinhold L; Krausewitz P; Ellinger J; Katemann C; Isaak A; Weber OM; Kuetting D; Attenberger U; Pieper CC; Sprinkart AM; Luetkens JA
Radiology; 2023 Sep; 308(3):e230427. PubMed ID: 37750774
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of the prostate imaging reporting and data system for the detection of prostate cancer by the results of targeted biopsy of the prostate.
Baur AD; Maxeiner A; Franiel T; Kilic E; Huppertz A; Schwenke C; Hamm B; Durmus T
Invest Radiol; 2014 Jun; 49(6):411-20. PubMed ID: 24598440
[TBL] [Abstract][Full Text] [Related]
35. MR image quality in local staging of prostate cancer: Role of PI-QUAL in the detection of extraprostatic extension.
Ponsiglione A; Stanzione A; Califano G; De Giorgi M; Collà Ruvolo C; D'Iglio I; Morra S; Longo N; Imbriaco M; Cuocolo R
Eur J Radiol; 2023 Sep; 166():110973. PubMed ID: 37453275
[TBL] [Abstract][Full Text] [Related]
36. Optimized Fast Dynamic Contrast-Enhanced Magnetic Resonance Imaging of the Prostate: Effect of Sampling Duration on Pharmacokinetic Parameters.
Othman AE; Falkner F; Martirosian P; Schraml C; Schwentner C; Nickel D; Nikolaou K; Notohamiprodjo M
Invest Radiol; 2016 Feb; 51(2):106-12. PubMed ID: 26447494
[TBL] [Abstract][Full Text] [Related]
37. High Diagnostic Performance of Short Magnetic Resonance Imaging Protocols for Prostate Cancer Detection in Biopsy-naïve Men: The Next Step in Magnetic Resonance Imaging Accessibility.
van der Leest M; Israël B; Cornel EB; Zámecnik P; Schoots IG; van der Lelij H; Padhani AR; Rovers M; van Oort I; Sedelaar M; Hulsbergen-van de Kaa C; Hannink G; Veltman J; Barentsz J
Eur Urol; 2019 Nov; 76(5):574-581. PubMed ID: 31167748
[TBL] [Abstract][Full Text] [Related]
38. Prospective comparison of PI-RADS version 2 and qualitative in-house categorization system in detection of prostate cancer.
Gaur S; Harmon S; Mehralivand S; Bednarova S; Calio BP; Sugano D; Sidana A; Merino MJ; Pinto PA; Wood BJ; Shih JH; Choyke PL; Turkbey B
J Magn Reson Imaging; 2018 Nov; 48(5):1326-1335. PubMed ID: 29603833
[TBL] [Abstract][Full Text] [Related]
39. T2- and diffusion-weighted magnetic resonance imaging at 3T for the detection of prostate cancer with and without endorectal coil: An intraindividual comparison of image quality and diagnostic performance.
Baur AD; Daqqaq T; Wagner M; Maxeiner A; Huppertz A; Renz D; Hamm B; Fischer T; Durmus T
Eur J Radiol; 2016 Jun; 85(6):1075-84. PubMed ID: 27161055
[TBL] [Abstract][Full Text] [Related]
40. Imaging quality and prostate MR: it is time to improve.
Giganti F; Allen C
Br J Radiol; 2021 Feb; 94(1118):20200934. PubMed ID: 33002388
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
